Sandbox osteomyelitis: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) |
||
| Line 28: | Line 28: | ||
</li> | </li> | ||
{{rx|Alternative regimen}} | {{rx|Alternative regimen}} | ||
* [[Linezolid]] 600 mg PO/IV q12h for 6 wk ± [[Rifampin]] 600–900 mg PO qd {{or2}} | * [[Linezolid]] 600 mg PO/IV q12h for 6 wk ± [[Rifampin]] 600–900 mg PO qd {{or2}} | ||
* [[Levofloxacin]] 500–750 mg PO/IV daily ± [[Rifampin]] 600–900 mg PO qd | * [[Levofloxacin]] 500–750 mg PO/IV daily ± [[Rifampin]] 600–900 mg PO qd | ||
</li> | </li> | ||
===Penicillin-sensitive streptococci=== | |||
==Specific Considerations== | ==Specific Considerations== | ||
Revision as of 18:08, 28 April 2015
Hematogenous Osteomyelitis
Acute Osteomyelitis in Adults
Acute Osteomyelitis in Children
Contiguous Osteomyelitis
Chronic Osteomyelitis in Adults – Pathogen-Based Therapy
Oxacillin-sensitive Staphylococcus aureus
- Vancomycin 15 mg/kg IV q12h for 4–6 wk
OR - Rifampin 600 mg PO qd AND Oxacillin 1.5–2 g IV q4h for 4–6 wk
Oxacillin-resistant Staphylococcus aureus
- Vancomycin 15 mg/kg IV q12h for 4–6 wk OR Daptomycin 6 mg/kg IV q24h
- Linezolid 600 mg PO/IV q12h for 6 wk ± Rifampin 600–900 mg PO qd
OR - Levofloxacin 500–750 mg PO/IV daily ± Rifampin 600–900 mg PO qd
Penicillin-sensitive streptococci
Specific Considerations
Vertebral osteomyelitis
Osteomyelitis in patients with diabetes mellitus
Osteomyelitis in patients with vascular insufficiency
SAPHO syndrome
Chronic recurrent multifocal osteomyelitis
Osteitis Pubis
Osteomyelitis of the Clavicle
Osteomyelitis in Hemodialysis Patients
Osteomyelitis in Patients with Sickle Cell Disease Gaucher’s Disease
Osteomyelitis in Injection Drug Users
Skeletal Mycobacterial Infection
Fungal Osteomyelitis
Brodie’s Abscess
Culture-Negative Osteomyelitis